| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/17/2015 | US8956657 Stable formulations for lyophilizing therapeutic particles |
| 02/17/2015 | US8956654 Sustained release dosage form |
| 02/17/2015 | US8956653 Preparations for effervescent formulations comprising cephalosporin and uses thereof |
| 02/17/2015 | US8956652 Effervescent rehydrating beverage tablet/granules |
| 02/17/2015 | US8956651 Oral formulations and lipophilic salts of methylnal trexone |
| 02/17/2015 | US8956649 Orally effective methylphenidate extended release powder and aqueous suspension product |
| 02/17/2015 | US8956648 Calciumphosphate-based nanoparticles as carrier-systems for photodynamic therapy |
| 02/17/2015 | US8956647 Pellet formulation for the treatment of the intestinal tract |
| 02/17/2015 | US8956645 Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids |
| 02/17/2015 | US8956644 Transdermal delivery systems |
| 02/17/2015 | US8956642 Bupivacaine formulation in a polyorthoester carrier |
| 02/17/2015 | US8956641 Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
| 02/17/2015 | US8956640 Block copolymers including a methoxyethyl methacrylate midblock |
| 02/17/2015 | US8956636 Methods and compositions for treating postoperative pain comprosing ketorolac |
| 02/17/2015 | US8956632 Alloplastic injectable dermal filler and methods of use thereof |
| 02/17/2015 | US8956629 Dental composition containing organic nanotube |
| 02/17/2015 | US8956619 Soluble CD80 as a therapeutic to reverse immune supression in cancer patients |
| 02/17/2015 | US8956613 Gemcitabine prodrugs and uses thereof |
| 02/17/2015 | US8956603 Amphiphilic compounds and self-assembling compositions made therefrom |
| 02/17/2015 | US8956602 Delivery of drugs |
| 02/17/2015 | US8956601 Therapeutic uses of mastic gum fractions |
| 02/17/2015 | US8956600 Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 02/17/2015 | US8956598 Hydrocarbon mixtures and use thereof |
| 02/17/2015 | US8956595 Calcium peroxyphosphates and use thereof in dental compositions |
| 02/17/2015 | US8956589 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases |
| 02/17/2015 | US8956162 Strip for the delivery of oral care compositions |
| 02/17/2015 | CA2855309C Method for producing patch, patch and package |
| 02/17/2015 | CA2788777C Policosanol nanoparticles |
| 02/17/2015 | CA2781780C Novel antiviral compounds |
| 02/17/2015 | CA2770554C Composition for prevention against spoilage by moulds and yeasts and uses and products related thereto |
| 02/17/2015 | CA2759163C Method for producing olmesartan medoxomil |
| 02/17/2015 | CA2726579C Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity |
| 02/17/2015 | CA2710977C 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 02/17/2015 | CA2704649C Tetracyclic dipyrano-coumarin compounds with anti-hiv and anti-mycobacterium tuberculosis activities |
| 02/17/2015 | CA2679971C Glucokinase activator |
| 02/17/2015 | CA2673976C Gel composition for treating mycosis |
| 02/17/2015 | CA2673918C Substituted isoquinoline and isoquinolinone derivatives |
| 02/17/2015 | CA2673916C Substituted isoquinolone and isoquinolinone derivatives as inhibitors of rho-kinase |
| 02/17/2015 | CA2671478C Non-nucleoside reverse transcriptase inhibitors |
| 02/17/2015 | CA2670763C 4-(1-amino-ethyl)-cyclohexylamine derivatives |
| 02/17/2015 | CA2669763C Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection |
| 02/17/2015 | CA2664112C Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases |
| 02/17/2015 | CA2657745C Pyrimidine derivatives and their use as pesticides |
| 02/17/2015 | CA2655509C Steroid-containing sustained release intraocular implants and related methods |
| 02/17/2015 | CA2651136C Substituted thieno-fused pyrimidines as p13k inhibitors |
| 02/17/2015 | CA2647423C Triazolone derivative |
| 02/17/2015 | CA2635842C Prokineticin 1 receptor antagonists |
| 02/17/2015 | CA2617760C Pyrimidine compounds as serotonin receptor modulators |
| 02/17/2015 | CA2616181C Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily |
| 02/17/2015 | CA2615378C Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof |
| 02/17/2015 | CA2612176C Dihydrothieno[2,3-d]pyramidine-6-carboxylic acid derivatives as pde9 inhibitors |
| 02/17/2015 | CA2609393C (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use |
| 02/17/2015 | CA2592532C Sesamin/episesamin compositions with improved bioavailability |
| 02/17/2015 | CA2592509C Benzazole analogues and uses thereof |
| 02/17/2015 | CA2578784C Compositions containing alpha-2-adrenergic agonist components |
| 02/17/2015 | CA2574767C Particulate constructs for release of active agents |
| 02/17/2015 | CA2541006C Tim-3 polypeptides |
| 02/17/2015 | CA2506129C 2'-branched nucleosides and flaviviridae mutation |
| 02/17/2015 | CA2494384C A segment of glycosylation-deficient hgf .alpha.-chain |
| 02/17/2015 | CA2336160C Use of compounds for treating hiv |
| 02/16/2015 | CA2851952A1 Supplement composition and methods of use |
| 02/12/2015 | WO2015021456A1 Small molecules to enhance p53 activity |
| 02/12/2015 | WO2015021396A2 Tricyclic benzoxaborole compounds and uses thereof |
| 02/12/2015 | WO2015021387A2 Formulations for control and prevention of periodontal and perimplant diseases and other diseases and conditions of the mouth, and supra and sub-gingival delivery methods and systems for such formulations |
| 02/12/2015 | WO2015021376A1 Immunoglobulin expression levels as biomarker for proteasome inhibitor response |
| 02/12/2015 | WO2015021324A1 Filanesib combined with pomalidomide displays enhanced anti-tumor activity |
| 02/12/2015 | WO2015021226A1 Analogs of vinaxanthone and xanthofulvin, methods of synthesis, and methods of treatments thereof |
| 02/12/2015 | WO2015021191A1 Formulations containing gamma secretase modulators |
| 02/12/2015 | WO2015021179A1 Microwave sterilization of pharmaceutical cyanoacrylate esters compositions |
| 02/12/2015 | WO2015021153A1 Sustained release dosage forms for a jak1 inhibitor |
| 02/12/2015 | WO2015021149A1 Inhibitors of ack1/tnk2 tyrosine kinase |
| 02/12/2015 | WO2015021134A2 Target binding molecules identified by kinetic target-guided synthesis |
| 02/12/2015 | WO2015021112A1 Disubstituted aryl oxy derivatives as sphingosine-1- phosphate receptors modulators |
| 02/12/2015 | WO2015021109A1 Disubstituted aryl azetidine derivatives as sphingosine-1-phosphate receptors modulators |
| 02/12/2015 | WO2015021092A1 Polyconjugates for delivery of rnai triggers to tumor cells in vivo |
| 02/12/2015 | WO2015020960A1 Novel lncrna polynucleotides |
| 02/12/2015 | WO2015020933A1 Thiazole orexin receptor antagonists |
| 02/12/2015 | WO2015020930A1 Oxazole orexin receptor antagonists |
| 02/12/2015 | WO2015020929A2 Rasal1 is a major tumor suppressor gene in thyroid cancer |
| 02/12/2015 | WO2015020878A1 Methods of treating pruritic conditions mediated through histamine h-4 receptors |
| 02/12/2015 | WO2015020565A1 Substituted [1,2,4]triazolo[4,3-a]pyridines exhibiting antagonist properties to adenosine a2a receptors, and use thereof |
| 02/12/2015 | WO2015020527A1 Biodegradable radiopaque stents and other implants |
| 02/12/2015 | WO2015020240A1 Entecavir microspheres and pharmaceutical composition for parenteral administration containing same |
| 02/12/2015 | WO2015020206A1 Tissue swelling material |
| 02/12/2015 | WO2015020194A1 Antisense oligonucleotide against acsl1 |
| 02/12/2015 | WO2015020191A1 Calcium agent |
| 02/12/2015 | WO2015020184A1 Aromatic compound |
| 02/12/2015 | WO2015020162A1 Aquaporin 3 expression enhancer and tissue repair accelerator |
| 02/12/2015 | WO2015020153A1 Beraprost-containing patch |
| 02/12/2015 | WO2015020139A1 Nanoparticles and nanoparticle composition, and method for producing nanoparticles and nonparticle composition |
| 02/12/2015 | WO2015020138A1 Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same |
| 02/12/2015 | WO2015020122A1 Urothelial cancer diagnosis and therapeutic agent |
| 02/12/2015 | WO2015020040A1 Medicine for preventing or suppressing survival of cancer cells and having organic acid polymer as active ingredient |
| 02/12/2015 | WO2015020026A1 Nucleic acid-encapsulating polymer micelle complex and method for producing same |
| 02/12/2015 | WO2015019359A1 Anti-acne compositions comprising bile acid-fatty acid conjugates |
| 02/12/2015 | WO2015019358A1 Anti-aging compositions comprising bile acid-fatty acid conjugates |
| 02/12/2015 | WO2015019334A1 Pharmaceutical composition combining diosmin and hesperidin and its use in neuropathic pain |
| 02/12/2015 | WO2015019325A1 Benzimidazolyl-methyl urea derivatives as alx receptor agonists |
| 02/12/2015 | WO2015019320A1 Pim kinase inhibitor combinations |
| 02/12/2015 | WO2015019256A1 Pharmaceutical composition of vilazodone and processes of preparation thereof |